Fresenius

• NCT07254637

  Collaborator, Phase 2, Not yet recruiting, 80 people, 28 Nov 2025

• NCT01810926

  Collaborator, Phase 2, Status unknown, 130 people, 14 Mar 2013

• Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network

  Fees or honoraria, 28 Sept 2026

• Estradiol transdermal spray for menopausal symptom management: From RCT to real-world evidence

  Fees or honoraria, Grants or research support, 17 Sept 2026

• Artificial intelligence-enabled electrocardiography for assessment of left ventricular systolic dysfunction in the era of foundation models

  Employment, 24 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov